Literature DB >> 33332749

MiR-19b-3p accelerates bone loss after spinal cord injury by suppressing osteogenesis via regulating PTEN/Akt/mTOR signalling.

Da Liu1, Bo Wang2, Min Qiu1, Ying Huang2.   

Abstract

Rapid and extensive bone loss, one of the skeletal complications after spinal cord injury (SCI) occurrence, drastically sacrifices the life quality of SCI patients. It has been demonstrated that microRNA (miRNA) dysfunction plays an important role in the initiation and development of bone loss post-SCI. Nevertheless, the effect of miR-19b-3p on bone loss after SCI is unknown and the accurate mechanism is left to be elucidated. The present work was conducted to explore the role of miR-19b-3p/phosphatase and tensin homolog deleted on chromosome ten (PTEN) axis on osteogenesis after SCI and further investigates the underlying mechanisms. We found that miR-19b-3p level was increased in the femurs of SCI rats with decreased autophagy. The overexpression of miR-19b-3p in bone marrow mesenchymal stem cells (BMSCs) targeted down-regulation of PTEN expression, facilitated protein kinase B (Akt) and mammalian target of rapamycin (mTOR) phosphorylation, and thereby suppressing BMSCs osteogenic differentiation via autophagy. Besides, the inhibiting effects of miR-19b-3p on osteogenic differentiation of BMSCs could be diminished by autophagy inducer rapamycin. Meanwhile, bone loss after SCI in rats was also reversed by antagomir-19b-3p treatment, suggesting miR-19b-3p was an essential target for osteogenic differentiation via regulating autophagy. These results indicated that miR-19b-3p was involved in bone loss after SCI by inhibiting osteogenesis via PTEN/Akt/mTOR signalling pathway.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Entities:  

Keywords:  autophagy; bone loss; miR-19b-3p; spinal cord injury

Mesh:

Substances:

Year:  2020        PMID: 33332749      PMCID: PMC7812263          DOI: 10.1111/jcmm.16159

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  41 in total

Review 1.  Normal bone anatomy and physiology.

Authors:  Bart Clarke
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

2.  Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.

Authors:  Dongsu Park; Joel A Spencer; Bong Ihn Koh; Tatsuya Kobayashi; Joji Fujisaki; Thomas L Clemens; Charles P Lin; Henry M Kronenberg; David T Scadden
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

3.  Changes of basic bone turnover parameters in short-term and long-term patients with spinal cord injury.

Authors:  Andreas Ludwig Reiter; Andreas Volk; Jens Vollmar; Bernd Fromm; Hans Juergen Gerner
Journal:  Eur Spine J       Date:  2006-07-08       Impact factor: 3.134

4.  A sensitive and reliable locomotor rating scale for open field testing in rats.

Authors:  D M Basso; M S Beattie; J C Bresnahan
Journal:  J Neurotrauma       Date:  1995-02       Impact factor: 5.269

Review 5.  Neurological aspects of spinal-cord repair: promises and challenges.

Authors:  Volker Dietz; Armin Curt
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

Review 6.  Autophagy as a second level protective process in conferring resistance to environmentally-induced oxidative stress.

Authors:  Michael N Moore
Journal:  Autophagy       Date:  2008-01-07       Impact factor: 16.016

7.  Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.

Authors:  Yongsheng Li; Caiqin Huo; Tao Pan; Lili Li; Xiyun Jin; Xiaoyu Lin; Juan Chen; Jinwen Zhang; Zheng Guo; Juan Xu; Xia Li
Journal:  Brief Bioinform       Date:  2019-01-18       Impact factor: 11.622

8.  Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling.

Authors:  Jun Yan; Bo Li; Jiang-Wei Chen; Sheng-Dan Jiang; Lei-Sheng Jiang
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

9.  Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.

Authors:  S Jenkinson; A A Kirkwood; N Goulden; A Vora; D C Linch; R E Gale
Journal:  Leukemia       Date:  2015-07-29       Impact factor: 11.528

10.  Dorsal Root Ganglion Maintains Stemness of Bone Marrow Mesenchymal Stem Cells by Enhancing Autophagy through the AMPK/mTOR Pathway in a Coculture System.

Authors:  Shuaishuai Zhang; Junqin Li; Huijie Jiang; Yi Gao; Pengzhen Cheng; Tianqing Cao; Donglin Li; Jimeng Wang; Yue Song; Bin Liu; Hao Wu; Chunmei Wang; Liu Yang; Guoxian Pei
Journal:  Stem Cells Int       Date:  2018-09-30       Impact factor: 5.443

View more
  3 in total

1.  MiR-19b-3p accelerates bone loss after spinal cord injury by suppressing osteogenesis via regulating PTEN/Akt/mTOR signalling.

Authors:  Da Liu; Bo Wang; Min Qiu; Ying Huang
Journal:  J Cell Mol Med       Date:  2020-12-17       Impact factor: 5.295

2.  CHNQD-00603 Promotes Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells by the miR-452-3p-Mediated Autophagy Pathway.

Authors:  Shanshan Xin; Shao-Ming Li; Ling Gao; Jing-Jing Zheng; Yan-Wei Wu; Chang-Lun Shao; Wen-Hao Ren; Keqian Zhi
Journal:  Front Cell Dev Biol       Date:  2021-12-21

3.  Inhibition of miRNA-100 facilitates bone regeneration defects of mesenchymal stem cells in osteoporotic mice through the protein kinase B pathway.

Authors:  Zhengqiu Dai; Guoqiang Wei
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.